GASTROGRAFIN 370 MG IODO/ML SOLUCIÓN ORAL Y RECTAL

V08AA01(WHO) 3,5-Bis(acetylamino)-2,4,6-triiodobenzoic acid 737-31-5 2140 DB00271 2055 5UVC90J1LKV5403H8VG7 D02240 CHEBI:53691 ChEMBL1201220 DTXSID0044521 Interactive image CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I InChI=1S/C11H9I3N2O4/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18/h1-2H3,(H,15,17)(H,16,18)(H,19,20)Key:YVPYQUNUQOZFHG-UHFFFAOYSA-N Diatrizoate, also known asamidotrizoate,Gastrografin, is acontrast agentused duringX-ray imaging.This includes visualizingveins, theurinary system,spleen, andjoints, as well ascomputer tomography(CT scan).It is given by mouth,injection into a vein, injection into the bladder, through anasogastric tube, orrectally. Relatively common side effects include vomiting, diarrhea, and skin redness.Other side effects include itchiness,kidney problems,low blood pressure, andallergic reactions.Diatrizoate is aniodinated ionic radiocontrast agentwith highosmolality. Diatrizoate was approved for medical use in the United States in 1954.It is on theWorld Health Organization's List of Essential Medicines.